News

On June 16, Senate Republicans unveiled their tax bill proposal, which would maintain tax credits for nuclear and battery ...
The Cleveland Fed model has a number of inputs found in the past to have at least some ability to forecast future interest rate trends. If you believe the model's current forecast is wrong, you would ...
"We'll gradually stop using contractors to do work that AI can handle," CEO Luis von Ahn said in the post. He noted that Duolingo would also look for AI use when making hiring decisions, and allocate ...
Shares of exchange-traded funds that hold alternative energy stocks plunged Wednesday, following the release of the US Senate ...
"I think the Fed will have a window to cut rates in September," Rick Rieder, BlackRock's chief investment officer of global fixed income and head of the firm's global allocation investment team, said ...
The Navy added $560.5 million to a previous contract with Fluor Marine Propulsion. The Arlington, Va., subsidiary of Fluor received the additional funding in late May to do nuclear propulsion work at ...
Shares of residential solar equipment firms Sunrun, SolarEdge and Enphase plummeted by 24% or more after a draft of the Senate budget bill showed tax credits expiring for solar-power equipment as soon ...
Communications-services companies fell as traders retreated from high-risk areas, in light of heightened risks of a major war in the Middle East.
The IPC Indice de Precios Y Cotizaciones is down 370.03 points or 0.65% today to 56676.82 --Down 1152.92 points or 1.99% over the last three trading days ...
Pros: Healthcare costs are skyrocketing and increasing every year, currently reaching the point of $5 trillion annually This is no longer sustainable. Medicare is expected to become insolvent by 2036 ...
Shares of banks and other financial institutions slipped as traders awaited developments in the conflict between Iran and Israel. AIB Group has returned to private ownership after the Irish state ...
Yum Brands named Chief Financial Officer Chris Turner as its next chief executive. Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion Deal would add a potential treatment for ...